A diverse set of enzymes targets in various pathways has been validated as potential drug targets for these diseases.
The exploitation of innate microbial capacities and/or the importation of novel diverse biosynthetic pathways have become one of the predominant research directions, with both being used to convert fermentable substrates into higher-order biofuels with long carbon chains ( > 6) approximating those of gasoline with rating octane value.
Along with the conventional role of the nucleolus in ribosome biogenesis, additional roles in the modulation of diverse molecular pathways have been described recently [13], [14].
Rather, we expect that a variety of pre-existing and diverse neurological pathways have been adapted to promote the development of human language [ 79].
A range of kinases and phosphatases acting downstream of diverse biological pathways have been shown to regulate the nucleocytoplasmic trafficking of class IIa HDACs [ 61].
Because of these signaling complexities and an increasing trend of drug-resistance, a molecular target that plays a central role in diverse oncogenic signaling pathways have long been sought.
Initial gene expression profiling of fibroblasts from human subjects with progeria syndromes and transfected cell models identified changes in sets of genes implicated in diverse pathways that have not always been consistent and have not been shown to be reversed by interventions such as treatment with FTIs [25], [26], [27], [28].
These pathways have diverse functions in regulating processes such as cell survival, proliferation or migration.
In the last decade, many diverse RNAi (RNA interference) pathways have been discovered that mediate gene silencing at epigenetic, transcriptional and post-transcriptional levels.
Diverse genetic causes and molecular pathways have been implicated, involving ion channels, and proteins needed for synaptic, regulatory, and developmental functions.
